LifeMD, Inc. (NASDAQ:LFMD) Receives $11.00 Consensus Price Target from Analysts

Shares of LifeMD, Inc. (NASDAQ:LFMD) have been given an average recommendation of “Buy” by the six brokerages that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $11.00.

Several brokerages recently weighed in on LFMD. Cantor Fitzgerald restated an “overweight” rating and set a $15.00 target price on shares of LifeMD in a research note on Tuesday, March 11th. HC Wainwright upped their price objective on shares of LifeMD from $12.00 to $14.00 and gave the company a “buy” rating in a report on Wednesday, March 12th. B. Riley upgraded shares of LifeMD to a “strong-buy” rating in a research note on Tuesday, March 11th. Finally, KeyCorp decreased their price target on shares of LifeMD from $10.00 to $7.00 and set an “overweight” rating for the company in a report on Wednesday, January 8th.

LifeMD Stock Performance

LFMD stock opened at $6.10 on Friday. LifeMD has a one year low of $3.99 and a one year high of $12.88. The firm has a market cap of $271.96 million, a price-to-earnings ratio of -9.53 and a beta of 2.22. The firm has a 50-day simple moving average of $5.42 and a two-hundred day simple moving average of $5.49.

LifeMD (NASDAQ:LFMD) last posted its earnings results on Monday, March 10th. The company reported ($0.02) EPS for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02. The firm had revenue of $64.26 million for the quarter, compared to analysts’ expectations of $57.43 million. As a group, equities analysts predict that LifeMD will post -0.56 earnings per share for the current fiscal year.

Insider Buying and Selling at LifeMD

In related news, CMO Jessica Friedeman sold 30,000 shares of the business’s stock in a transaction on Friday, March 14th. The shares were sold at an average price of $5.66, for a total transaction of $169,800.00. Following the completion of the transaction, the chief marketing officer now directly owns 170,000 shares in the company, valued at $962,200. The trade was a 15.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Justin Schreiber sold 50,000 shares of the stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $7.55, for a total value of $377,500.00. Following the sale, the chief executive officer now directly owns 2,653,715 shares in the company, valued at $20,035,548.25. This represents a 1.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 15.97% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of LFMD. Prudential Financial Inc. increased its holdings in shares of LifeMD by 19.3% during the 4th quarter. Prudential Financial Inc. now owns 13,605 shares of the company’s stock valued at $67,000 after purchasing an additional 2,200 shares in the last quarter. Rhumbline Advisers boosted its stake in shares of LifeMD by 6.1% during the 4th quarter. Rhumbline Advisers now owns 48,689 shares of the company’s stock worth $241,000 after acquiring an additional 2,814 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of LifeMD by 26.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 14,012 shares of the company’s stock valued at $70,000 after acquiring an additional 2,895 shares during the period. Geode Capital Management LLC increased its stake in shares of LifeMD by 0.4% in the 4th quarter. Geode Capital Management LLC now owns 822,217 shares of the company’s stock valued at $4,071,000 after purchasing an additional 2,984 shares in the last quarter. Finally, Magnus Financial Group LLC raised its holdings in LifeMD by 31.1% in the 4th quarter. Magnus Financial Group LLC now owns 16,000 shares of the company’s stock worth $79,000 after purchasing an additional 3,792 shares during the period. 35.52% of the stock is owned by institutional investors and hedge funds.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.